20.1402.34% ( +0.460 )
Delay Closed: Nov 16, 16:08:11Valuation
Current ValuationThe current P/E ratio is 11.10, below the reasonable range, cheaper than 99.23% of the time in the past 3 years, and the industry ranks 7/22, the industry Median 11.10.
11.1xP/E
HK$20.14Stock price
HK$1.81Earnings per share
11.1xP/E
Stock priceHK$20.14Earnings per shareHK$1.81
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 24.64x
- Typical range
- 14.68x–29.43x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.10x
05101520
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.10x
0x4x8x12x16x20x
| Name/Symbol | |||
|---|---|---|---|
02367HKGIANT BIOGENE | 11.10x | 2.56% | HK$21.38B |
02145HKCHICMAX | 11.22x | 48.24% | HK$8.87B |
02530HKNUMANS | 11.97x | -- | HK$720.00M |
01455HKFOURACE IND GP | 10.31x | -- | HK$377.18M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
